John Conibear
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Advanced Radiotherapy Techniques 8
- Oncology 13
- Cancer Immunotherapy and Biomarkers 9
- COVID-19 and healthcare impacts 2
- Co-authors
- Gloria Barone (2 shared papers)Paul HS Shaw (2 shared papers)Riyaz N.H. Shah (2 shared papers)Siow Ming Lee (2 shared papers)Christian H. H. Ottensmeier (2 shared papers)Sanjay Popat (2 shared papers)Kristian Brock (2 shared papers)Gary Middleton (2 shared papers)
- Journals
- Clinical Oncology (6 papers)Annals of Oncology (3 papers)Lung Cancer (2 papers)BMJ Open (2 papers)Nature Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
John Conibear
37 papers receiving 3.9k citations
John Conibear's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 2k
- Cancer Research 658
- Immunology 569
- Radiation 155
- Pulmonary and Respiratory Medicine 496
Countries citing papers authored by John Conibear
This map shows the geographic impact of John Conibear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Conibear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Conibear more than expected).
Fields of papers citing papers by John Conibear
This network shows the impact of papers produced by John Conibear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Conibear. The network helps show where John Conibear may publish in the future.
Co-authors
The 25 scholars most cited alongside John Conibear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Hit paper breakdown → | 2017 | 1030 |
| 2 | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Hit paper breakdown → | 2018 | 510 |
| 3 | 2017 | 469 | |
| 4 | 2017 | 369 | |
| 5 | Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial Hit paper breakdown → | 2019 | 330 |
| 6 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 7 | 2020 | 133 | |
| 8 | 2022 | 93 | |
| 9 | 2022 | 85 | |
| 10 | 2019 | 78 | |
| 11 | 2020 | 75 | |
| 12 | 2018 | 62 | |
| 13 | 2021 | 51 | |
| 14 | 2013 | 44 | |
| 15 | 2016 | 41 | |
| 16 | 2011 | 27 | |
| 17 | 2018 | 27 | |
| 18 | 2024 | 27 | |
| 19 | 2019 | 24 | |
| 20 | 2021 | 23 |
About John Conibear
John Conibear is a scholar working on Radiation, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Advanced Radiotherapy Techniques (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), T-cell and B-cell Immunology (2 papers), COVID-19 and healthcare impacts (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (2k citations), Cancer Research (658 citations), Immunology (569 citations), Radiation (155 citations) and Pulmonary and Respiratory Medicine (496 citations). John Conibear has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Gloria Barone, Paul HS Shaw, Riyaz N.H. Shah, Siow Ming Lee, Christian H. H. Ottensmeier, Sanjay Popat, Kristian Brock, Gary Middleton, Lucinda Jane Billingham and Yvonne Summers. Their work appears in journals such as Clinical Oncology, Annals of Oncology, Lung Cancer, BMJ Open and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.